Clinical Trial: NCT03661892
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets
Status:
COMPLETEDPhase:
Early Phase 1| Lead Sponsor: | University of Arizona |
| Information Provided By: | University of Arizona |
| Last Update Posted: | 2021-04-29 |
Study Overview
Brief Summary
In patients with cancer induced bone pain, addition of Syndros will improve pain relief and decrease opioid requirement.
Official Title
Title A Pilot Trial to Evaluate Syndros in Decreasing Opioid Requirement in Patients With Bone Metastases From Breast Cancer
Conditions
Bone Metastases, Breast Cancer, Pain
Intervention / Treatment
- Drug: Syndros
Other Study ID Numbers
- 1808852902
- NCI-2018-01916
Start Date (Actual)
2018-12-19
Primary Completion Date (Actual)
2020-10-30
Study Completion Date (Actual)
2021-04-26
Enrollment (Actual)
14
Study Type
Interventional
Phase
Early Phase 1
| Lead Sponsor: | University of Arizona |
| Information Provided By: | University of Arizona |
| Last Update Posted: | 2021-04-29 |
Study Overview
Brief Summary
In patients with cancer induced bone pain, addition of Syndros will improve pain relief and decrease opioid requirement.
Official Title
Title A Pilot Trial to Evaluate Syndros in Decreasing Opioid Requirement in Patients With Bone Metastases From Breast Cancer
Conditions
Bone Metastases, Breast Cancer, Pain
Intervention / Treatment
- Drug: Syndros
Other Study ID Numbers
- 1808852902
- NCI-2018-01916
Start Date (Actual)
2018-12-19
Primary Completion Date (Actual)
2020-10-30
Study Completion Date (Actual)
2021-04-26
Enrollment (Actual)
14
Study Type
Interventional
Phase
Early Phase 1